Identification and characterization of an IκB kinase

Cell

Volumn 90, Issue 2, 1997, Pages 373-383

  Régnier, Catherine H ^a   Song, Ho Yeong ^a   Gao, Xiong ^a   Goeddel, David V ^a   Cao, Zhaodan ^a   Rothe, Mike ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; CHUK PROTEIN, HUMAN; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPA B KINASE; NF-KAPPA B KINASE; ONCOPROTEIN; RELB PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ARTICLE; ENZYME ANALYSIS; GENE ACTIVATION; GENE OVEREXPRESSION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; CHEMISTRY; ENZYME ACTIVATION; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MUTAGENESIS; PHOSPHORYLATION; PHYSIOLOGY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; YEAST;

ANIMALIA; MAMMALIA;

CLONING, MOLECULAR; ENZYME ACTIVATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; YEASTS;

EID: 0031586174     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80344-X     Document Type: Article

References (56)

1. Baeuerle, P.A., and Henkel, T. (1994). Function and activation of NFκB in the immune system. Annu. Rev. Immunol. 12, 141-179.
2. Baeuerle, P.A., and Baltimore, D. (1996). NF-κB: ten years after. Cell 87, 13-20.
3. Beg, A.A., Finco, T.S., Nantermet, P.V., and Baldwin, A.S. (1993). Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13, 3301-3310.
4. Beg, A.A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
5. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
6. Boldin, M .P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease in Fas/APO-1 and TNF receptor-induced cell death. Cell 85, 803-815.
7. Brockmann, J.A., Scherer, D.C., McKinsey, T.A., Hall, S.M., Qi, X., Lee, W.Y., and Ballard, D.W. (1995). Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15, 2809-2818.
8. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., and Goeddel, D.V. (1996a). TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446.
9. Cao, Z., Henzel, W.J., and Gao, X. (1996b). IRAK: a kinase associated with the interleukin-1 receptor. Science 277, 1128-1131.
10. Chen, Z.J., Parent, L., and Maniatis, T. (1996). Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862.
11. Cheng, G., Cleary, A.M., Ye, Z.-s., Hong, D., Lederman, S., and Baltimore, D. (1995). Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498.
12. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
13. Chinnaiyan, A.M., O'Rourke, K., Yu, G.-L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J., and Dixit, V.M. (1996a). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
14. Chinnaiyan, A.M., Tepper, C.G., Seidin, M.F., O'Rourke, K., Kischkel, F.C., Hellbardt, S., Krammer, P.H., Peter, M.E., and Dixit, V.M. (1996b). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 277,4961-4965.
15. Choi, K.Y., Scatterberg, B., Lyons, D.M., and Ellion, E.A. (1994). Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating of S. cerevisiae. Cell 78, 499-512.
16. Connelly, M.A., and Marcu, K.B. (1995). CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains aserine-threonine kinase catalytic domain. Cell. Mol. Biol. Res. 41, 537-549.
17. Dinarello, C.A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
18. Fields, S., and Song, O.-k. (1989). A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
19. Gedrich, R.W., Gilfillan, M.C., Duckett, C.S., Van Dongen, J.L., and Thompson, C.B. (1996). CD30 contains two binding sites with different receptor specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271, 12852-12858.
20. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor-1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
21. Hsu, H., Shu, H.-B., Pan, M.-G., and Goeddel, D.V. (1996a). TRADD-TRAF2 and TRAD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways. Cell 84, 299-308.
22. Hsu, H., Huang, J., Shu, H.-B., Baichwal, V., and Goeddel, D.V. (1996b). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
23. Hu, H.M., O'Rourke, K., Boguski, M.S., and Dixit, V.M. (1994). A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072.
24. Ishida, T., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., and Inoue, J.-i. (1996). TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93, 9437-9442.
25. Kitson, J., Raven, T., Jiang, Y.-P., Goeddel, D.V., Giles, K.M., Pun, K.-T., Grinham, C.J., Brown, R., and Farrow, S.N. (1996). A deathdomain-containing receptor that mediates apoptosis. Nature 384, 372-375.
26. Lee, F.S., Hagler, J., Chen, Z.J., and Maniatis, T. (1997). Activation of the IκBα kinase complex by MEKKI, a kinase of the JNK pathway. Cell 88, 213-222.
27. Lee, S.Y., Lee, S.L., Kandala, G., Liou, M.-L., Liou, H.-C., and Choi, Y. (1996). CD30-TRAF interaction: NF-κB activation and binding specificity. Proc. Natl. Acad. Sci. USA 93, 9699-9703.
28. Lenardo, M., and Baltimore, D. (1989). NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
29. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., Ikeda, J.-E., MacKenzie, A., and Korneluk, R.B. (1996). Suppresion of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349-353.
30. Liu, Z.-g., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
31. Malinin, N.L., Boldin, M.P., Kovalenko, A.V., and Wallach, D. (1997). MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
32. Mock, B.A., Connelly, M.A., McBride.O.W., Kozak, C.A., and Marcu, K.B. (1995). CHUK, a conserved helix-loop-helix ubiquitous kinase, maps to human chromosome 10 and mouse chromosome 19.Genomics 27, 348-351.
33. Mosialos, G., Birkenbach, M.,Yalamanchill, R., VanArsdale, T., Ware, C., and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
34. Muzio, M.,Chinnaiyan, A.M., Kischkel, F., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
35. Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C.F., Yagita, H., and Okumura, K. (1996). TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271, 14661-14664.
36. Orth, K., and Dixit, V.M. (1997). Bikand Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis. J. Biol. Chem. 272, 8841-8844.
37. Osborn, L., Kunkel, S., and Nabel, G.J. (1989). Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86, 2336-2340.
38. Robinson, M.J., and Cobb, M.H. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186.
39. Rothe, M., Wong, S.C., Henzel, W.J., and Goeddel, D.V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
40. Rothe, M., Sarma, V., Dixit, V.M., and Goeddel, D.V. (1995a). TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424-1427.
41. Rothe, M., Pan, M.-G., Henzel, W.J., Ayres, T.M., and Goeddel, D.V. (1995b). The TNF receptor 2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252.
42. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press).
43. Schall, T.J., Lewis, M., Koller, K.J., Lee, A., Rice, G.C., Wong, G.H.W., Gatanaga, T., Granger, G.A., Lentz, R., Raab, H., Kohr, W.J., and Goeddel, D.V. (1990). Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361-370.
44. Schindler, U., and Baichwal, V.R. (1994). Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol. Cell. Biol. 14, 5820-5831.
45. Schouten, G.J., Vertegaal, A.C.O., Whiteside, ST., Israël, A., Toebes, M., Dorsman, J.C., van der Eb, A.J., and Zantema, A. (1997). IκB-α is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 76, 3133-3144.
46. Scott, M.L., Fujita, T., Liou, H.-C., Nolan, G.P., and Baltimore, D. (1993). The p65 subunit of NF-κB regulates kB by two distinct mechanisms. Genes Dev. 7, 1266-1276.
47. Shu, H.-B.,Takeuchi, M., and Goddel, D.V. (1996). The tumor necrosis factor receptor 2 signal transducers TRAF2 and C-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. USA 93, 13973-13978.
48. Smith, C.A., Farrah, T., and Goodwin, R.G.(1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
49. Song, H.Y., Régnier, C.H., Kirschning, C.J., Ayres, T.M., Goeddel, D.V., and Rothe, M. (1997). TNF-mediated kinase cascades: bifurcation of NF-κB and JNK/SAPK pathways at TRAF2. Proc. Natl. Acad. Sci. USA, in press.
50. Stanger, B.Z., Leder, P., Lee, T.-H., Kim, E., and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95)in yeast and causes cell death. Cell 81, 513-523.
51. Thanos, D., and Maniatis, T. (1995). NF-κB: a lesson in family values. Cell 80, 529-532.
52. Ting, A.T., Pimentel-Muiños, F.X., and Seed, B. (1996). RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/ APO-1-initiated apoptosis. EMBO J. 15, 6189-6196.
53. Traenckner, E.B.-M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., and Baeuerle, P.A. (1995). Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
54. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. (1996). Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789.
55. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D., and Miyamoto, S. (1995). Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735.
56. Wang, C.-Y., Mayo, M.W., and Baldwin, A.S. (1996). TNF-and cancer therapy-induced apoptosis: potentiation byinhibition of NF-κB. Science 274, 784-787.